Carbapenem-resistant Gram-negative pathogens associated with septic shock: a review of 120 cases
Makaleler > Tam Makale · 2022
Yazarlar: Uğur Önal, Deniz Akyol, Merve Mert, Dilşah Başkol, Seichan Chousein Memetali, Gamze Şanlıdağ, Buse Kenanoğlu, Ayşe Uyan-Önal, Günel Quliyeva, Cansu Bulut Avşar, Damla Akdağ, Melike Demir, Hüseyin Aytaç Erdem, Ümit Kahraman, Osman Bozbıyık, Erkin Özgiray, Devrim Bozkurt, Funda Karbek Akarca, Kubilay Demirağ, İlkin Çankayalı, Mehmet Uyar, Feriha Çilli, Bilgin Arda, Tansu Yamazhan, Hüsnü Pullukçu, Meltem Işıkgöz Taşbakan, Hilal Sipahi, Sercan Ulusoy, Oguz Resat Sipahi
Journal of Chemotherapy, Uluslararası, Wos, 2022, cilt 34, ss 436-445
DOI: 10.1080/1120009x.2022.2064703
Özet
This study aimed to evaluate the influencing variables for outcomes in patients with septic shock having culture-proven carbapenem-resistant Gram-negative pathogens. It included 120 patients (mean age 64.29 ± 1.35 years and 58.3% female). The mean Sequential Organ Failure Assessment score during septic shock diagnosis was found to be 11.22 ± 0.43 and 9 ± 0.79 among the patients with mortality and among the survivors, respectively (P = 0.017). The logistic regression analysis showed that empirical treatment as mono Gram-negative bacteria-oriented antibiotic therapy (P = 0.016, odds ratio (OR) = 17.730, 95% confidence interval (CI): 1.728-182.691), Charlson Comorbidity Index >2 (P = 0.032, OR = 7.312, 95% CI: 5.7-18.3), and systemic inflammatory response syndrome score 3 or 4 during septic shock diagnosis (P = 0.014, OR = 5.675, 95% CI: 1.424-22.619) were found as independent risk factors for day 30 mortality. Despite early diagnosis and effective management of patients with septic shock, the mortality rates are quite high in CRGNP-infected patients.